News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
173 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17923)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
BioMidwest
Simplify Healthcare Joins the Ranks of the Inc. 5000 Fastest Growing Private Companies
Simplify Healthcare is pleased to join the 37th annual Inc. 5000 list of the fastest growing companies, reflecting our 150% growth.
August 22, 2018
·
2 min read
Deals
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder at $55.50 Per Share
Medpace Holdings, Inc. today announced the pricing of the previously announced secondary offering of 5,224,997 shares of its common stock by investment funds affiliated with Cinven Capital Management
August 22, 2018
·
4 min read
FDA
Dompé receives FDA approval of Oxervate™ eye drops (cenegermin-bkbj ophthalmic solution), first-in-class recombinant human nerve growth factor with potential to completely heal rare neurotrophic keratitis
Oxervate is the first-ever application of a human nerve growth factor as drug or treatment, and is the first-ever topical biologic medication approved in ophthalmology.
August 22, 2018
·
9 min read
Previous
18 of 18